* ICU Medical Inc ICUI.OQ ICUI.O is expected to show a rise
in quarterly revenue when it reports results on November 3.
* The San Clemente, California-based company is expected to
report a 3.8% increase in revenue to $314.3 million from $302.8
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for ICU Medical Inc is for
earnings of $1.80 per share. For the same quarter last year, the
company reported earnings of $1.90 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for ICU Medical Inc
is $286, about 17.3% above its last closing price
of $236.43.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 302021 1.65 1.64 1.88 Beat 14.6
Mar. 312021 1.50 1.50 1.62 Beat 7.8
Dec. 312020 1.52 1.51 1.77 Beat 17.2
Sep. 302020 1.31 1.31 1.90 Beat 45.4
Jun. 1.23 1.24 1.65 Beat 33.1
302020
Mar. 312020 1.65 1.63 1.81 Beat 11.3
Dec. 312019 1.58 1.63 1.94 Beat 19
Sep. 302019 1.63 1.62 1.65 Beat 2.1
This summary was machine generated November 2 at 02:08 GMT. All
figures in US dollars unless otherwise stated